Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [18]
In the citing paper
“Teratoma formation has been observed in partially reprogrammed animals, particularly when c-Myc is used in the partial rejuvenation cocktail (Abad et al., 2013; Ocampo et al., 2016; Ohnishi et al., 2014; Senís et al., 2018)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Abad et al., 2013
In the citing paper
“cellular reprogramming to pluripotency, although associated with tumor development (e.g., teratoma formation), can be achieved in vivo in mice by the forced expression of the Yamanaka factors”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“Although previous studies have indicated that expression of the Yamanaka factors in vivo can lead to cancer development or teratoma formation (Abad et al., 2013;Ohnishi et al., 2014), here, we demonstrate that tumor formation can be avoided by short-term induction of OSKM.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“The Yamanaka factors possess oncogenic properties, which can lead to teratoma formation when persistently overexpressed in vivo (Abad et al., 2013; Ohnishi et al., 2014).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Abad et al., 2013
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Embryonic stem cell potency fluctuates with endogenous retrovirus activity
Macfarlan, T. S., Gifford, W. D., Driscoll, S., Lettieri, K., Rowe, H. M., Bonanomi, D., Firth, A., Singer, O., Trono, D., & Pfaff, S. L. (2012) · Nature · doi:10.1038/nature11244 · Cited by 981
Hanna, J., Cheng, A. W., Saha, K., Kim, J., Lengner, C. J., Soldner, F., Cassady, J. P., Muffat, J., Carey, B. W., & Jaenisch, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004584107 · Cited by 847
Cited by
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Despite this, in vivo reprogramming efficiencies are still very low (2), and therefore, intrinsic reprogramming barriers must also exist in vivo.”
BackgroundIn Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988
“Cyclic In Vivo Induction of Reprogramming Factors Does Not Lead to Tumor Formation Previous studies have shown that the in vivo induction of OSKM leads to teratoma formation and the development of cancer (Abad et al., 2013; Ohnishi et al., 2014).”
InfluentialReprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
Modulating the stem cell niche for tissue regeneration
Lane, S. W., Williams, D. A., & Watt, F. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2978 · Cited by 615
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589
“Recent studies have shown that OSKM overexpression in mice results in cell dedifferentiation in multiple tissue types and reprogramming into iPSCs in vivo (3, 4).”
BackgroundMethodSelf-citationDerivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency
Yang, Y., Liu, B., Xu, J., Wang, J., Wu, J., Shi, C., Xu, Y., Dong, J., Wang, C., Lai, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.005 · Cited by 502
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460
Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., Zhang, X., Qin, G., He, S.-H., Zimmerman, A., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.020 · Cited by 439
Ageing and rejuvenation of tissue stem cells and their niches
Brunet, A., Goodell, M. A., & Rando, T. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00510-w · Cited by 407
De Los Angeles, A., Ferrari, F., Xi, R., Fujiwara, Y., Benvenisty, N., Deng, H., Hochedlinger, K., Jaenisch, R., Lee, S., Leitch, H. G., et al. (2015) · Nature · doi:10.1038/nature15515 · Cited by 396
Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly
Ishiuchi, T., Enriquez-Gasca, R., Mizutani, E., Bošković, A., Ziegler-Birling, C., Rodriguez-Terrones, D., Wakayama, T., Vaquerizas, J. M., & Torres-Padilla, M.-E. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3066 · Cited by 335
Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes
Cheng, C.-W., Villani, V., Buono, R., Wei, M., Kumar, S., Yilmaz, O. H., Cohen, P., Sneddon, J. B., Perin, L., & Longo, V. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.040 · Cited by 331
Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice
Chen, Y., Lüttmann, F. F., Schoger, E., Schöler, H. R., Zelarayán, L. C., Kim, K.-P., Haigh, J. J., Kim, J., & Braun, T. (2021) · Science · doi:10.1126/science.abg5159 · Cited by 297
Establishment of mouse expanded potential stem cells
Yang, J., Ryan, D. J., Wang, W., Tsang, J. C.-H., Lan, G., Masaki, H., Gao, X., Antunes, L., Yu, Y., Zhu, Z., et al. (2017) · Nature · doi:10.1038/nature24052 · Cited by 297
Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle
Chiche, A., Le Roux, I., von Joest, M., Sakai, H., Aguín, S. B., Cazin, C., Salam, R., Fiette, L., Alegria, O., Flamant, P., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.11.020 · Cited by 295
Targeting senescent cells in translational medicine
Paez‐Ribes, M., González‐Gualda, E., Doherty, G. J., & Muñoz‐Espín, D. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810234 · Cited by 293
Moradi, S., Mahdizadeh, H., Šarić, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1455-y · Cited by 287
Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing
Mahmoudi, S., Mancini, E., Xu, L., Moore, A., Jahanbani, F., Hebestreit, K., Srinivasan, R., Li, X., Devarajan, K., Prélot, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1658-5 · Cited by 285
Epigenetic changes during aging and their reprogramming potential
Kane, A. E., & Sinclair, D. A. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1570075 · Cited by 283
Browder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00183-2 · Cited by 253
SOX2 Reprograms Resident Astrocytes into Neural Progenitors in the Adult Brain
Niu, W., Zang, T., Smith, D. K., Vue, T. Y., Zou, Y., Bachoo, R., Johnson, J. E., & Zhang, C.-L. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.03.006 · Cited by 218
Evaluating totipotency using criteria of increasing stringency
Posfai, E., Schell, J. P., Janiszewski, A., Rovic, I., Murray, A., Bradshaw, B., Yamakawa, T., Pardon, T., El Bakkali, M., Talon, I., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00609-2 · Cited by 212
In Vivo Activation of a Conserved MicroRNA Program Induces Mammalian Heart Regeneration
Aguirre, A., Montserrat, N., Zacchigna, S., Nivet, E., Hishida, T., Krause, M. N., Kurian, L., Ocampo, A., Vazquez-Ferrer, E., Rodriguez-Esteban, C., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.10.003 · Cited by 197
Therapeutic interventions for aging: the case of cellular senescence
Soto-Gamez, A., & Demaria, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.004 · Cited by 192
Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity
Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019) · Aging Cell · doi:10.1111/acel.12877 · Cited by 190
Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
Gill, D., Parry, A., Santos, F., Okkenhaug, H., Todd, C. D., Hernando-Herraez, I., Stubbs, T. M., Milagre, I., & Reik, W. (2022) · eLife · doi:10.7554/elife.71624 · Cited by 185
Senescence promotes in vivo reprogramming through p16INK4a and IL‐6
Mosteiro, L., Pantoja, C., de Martino, A., & Serrano, M. (2018) · Aging Cell · doi:10.1111/acel.12711 · Cited by 182
Self-citationKLF4 transcription factor in tumorigenesis
He, Z., He, J., & Xie, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01416-y · Cited by 177
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Chehelgerdi, M., Behdarvand Dehkordi, F., Chehelgerdi, M., Kabiri, H., Salehian-Dehkordi, H., Abdolvand, M., Salmanizadeh, S., Rashidi, M., Niazmand, A., Ahmadi, S., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01873-0 · Cited by 175
Bile acid: a potential inducer of colon cancer stem cells
Farhana, L., Nangia-Makker, P., Arbit, E., Shango, K., Sarkar, S., Mahmud, H., Hadden, T., Yu, Y., & Majumdar, A. P. N. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0439-4 · Cited by 173
Totipotency: What It Is and What It Is Not
Condic, M. L. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0364 · Cited by 169
Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
Berezovsky, A. D., Poisson, L. M., Cherba, D., Webb, C. P., Transou, A. D., Lemke, N. W., Hong, X., Hasselbach, L. A., Irtenkauf, S. M., Mikkelsen, T., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.006 · Cited by 166
Regenerative medicine: Historical roots and potential strategies in modern medicine
Sampogna, G., Guraya, S. Y., & Forgione, A. (2015) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2015.05.002 · Cited by 164
Turning back time with emerging rejuvenation strategies
Mahmoudi, S., Xu, L., & Brunet, A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0206-0 · Cited by 161
Tissue Engineering and Regenerative Medicine: A Year in Review
Harrison, R. H., St‐Pierre, J., & Stevens, M. M. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0668 · Cited by 159
Deficiency of microRNA miR-34a expands cell fate potential in pluripotent stem cells
Choi, Y. J., Lin, C.-P., Risso, D., Chen, S., Kim, T. A., Tan, M. H., Li, J. B., Wu, Y., Chen, C., Xuan, Z., et al. (2017) · Science · doi:10.1126/science.aag1927 · Cited by 158
Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions
Wang, J., Yu, H., Ma, Q., Zeng, P., Wu, D., Hou, Y., Liu, X., Jia, L., Sun, J., Chen, Y., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.023 · Cited by 156
Ribas, L., Liew, W. C., Díaz, N., Sreenivasan, R., Orbán, L., & Piferrer, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609411114 · Cited by 152
The dualistic origin of human tumors
Liu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.004 · Cited by 148
“As uterine implantation serves as the filter to selectively eliminate the highly genomically abnormal embryo from further development, the tumors in this group largely show immature tissue resembling that from primitive organs without identifiable mutations [18,19,176,177].”
SUMO Safeguards Somatic and Pluripotent Cell Identities by Enforcing Distinct Chromatin States
Cossec, J.-C., Theurillat, I., Chica, C., Búa Aguín, S., Gaume, X., Andrieux, A., Iturbide, A., Jouvion, G., Li, H., Bossis, G., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.001 · Cited by 142
Molecular Obstacles to Clinical Translation of iPSCs
Tapia, N., & Schöler, H. R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.017 · Cited by 141
The Information Theory of Aging
Lu, Y. R., Tian, X., & Sinclair, D. A. (2023) · Nature Aging · doi:10.1038/s43587-023-00527-6 · Cited by 141
Role of cell–cell adhesion complexes in embryonic stem cell biology
Pieters, T., & Roy, F. M. V. (2014) · Journal of Cell Science · doi:10.1242/jcs.146720 · Cited by 141
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
Al Abbar, A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0046 · Cited by 134
Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming
Chondronasiou, D., Gill, D., Mosteiro, L., Urdinguio, R. G., Berenguer‐Llergo, A., Aguilera, M., Durand, S., Aprahamian, F., Nirmalathasan, N., Abad, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13578 · Cited by 133
Self-citationCapturing Totipotent Stem Cells
Baker, C. L., & Pera, M. F. (2018) · Cell stem cell · doi:10.1016/j.stem.2017.12.011 · Cited by 133
Pai, V. P., Lemire, J. M., Paré, J.-F., Lin, G., Chen, Y., & Levin, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1877-14.2015 · Cited by 130
Cieślar‐Pobuda, A., Knoflach, V., Ringh, M. V., Stark, J., Likus, W., Siemianowicz, K., Ghavami, S., Hudecki, A., Green, J. L., & Łoś, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.017 · Cited by 128
Cellular reprogramming and epigenetic rejuvenation
Simpson, D. J., Olova, N. N., & Chandra, T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01158-7 · Cited by 126
The “life code”: A theory that unifies the human life cycle and the origin of human tumors
Liu, J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.005 · Cited by 126
Wang, C., Rabadan Ros, R., Martinez-Redondo, P., Ma, Z., Shi, L., Xue, Y., Guillen-Guillen, I., Huang, L., Hishida, T., Liao, H.-K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23353-z · Cited by 119
In Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice.
Rodríguez-Matellán, A., Alcazar, N., Hernández, F., Serrano, M., & Ávila, J. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.09.010 · Cited by 116
“Reprogrammable i4F-B mice were generated as previously described (Abad et al., 2013).”
BackgroundMethodInfluentialSelf-citationIn vivo partial cellular reprogramming enhances liver plasticity and regeneration
Hishida, T., Yamamoto, M., Hishida-Nozaki, Y., Shao, C., Huang, L., Wang, C., Shojima, K., Xue, Y., Hang, Y., Shokhirev, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110730 · Cited by 116
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 112
Reprogramming the genome to totipotency in mouse embryos
Zhou, L.-Q., & Dean, J. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.09.006 · Cited by 109
Kim, E. Y., Lee, K.-B., & Kim, M. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.289 · Cited by 108
Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
Wuputra, K., Ku, C., Wu, D., Lin, Y., Saito, S., & Yokoyama, K. K. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01584-0 · Cited by 104
The role of pluripotency factors to drive stemness in gastrointestinal cancer
Müller, M., Hermann, P. C., Liebau, S., Weidgang, C. E., Seufferlein, T. T. W., Kleger, A., & Perkhofer, L. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.005 · Cited by 97
Macip, C. C., Hasan, R., Hoznek, V., Kim, J., Metzger, L. E., Sethna, S., & Davidsohn, N. (2023) · doi:10.1101/2023.01.04.522507 · Cited by 95
Macip, C. C., Hasan, R., Hoznek, V., Kim, J., Lu, Y. R., Metzger, L. E., Sethna, S., & Davidsohn, N. (2024) · Cellular Reprogramming · doi:10.1089/cell.2023.0072 · Cited by 95
“Teratoma formation has been observed in partially reprogrammed animals, particularly when c-Myc is used in the partial rejuvenation cocktail (Abad et al., 2013; Ocampo et al., 2016; Ohnishi et al., 2014; Senís et al., 2018).”
BackgroundBeyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment
Kufe, D. W. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa082 · Cited by 94
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M., Das, S. K., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 93
Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
The long and winding road of reprogramming-induced rejuvenation
Yücel, A. D., & Gladyshev, V. N. (2024) · Nature Communications · doi:10.1038/s41467-024-46020-5 · Cited by 91
Animal regeneration: ancestral character or evolutionary novelty?
Slack, J. M. W. (2017) · EMBO Reports · doi:10.15252/embr.201643795 · Cited by 91
Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure
Yang, Y., Adachi, K., Sheridan, M. A., Alexenko, A. P., Schust, D. J., Schulz, L. C., Ezashi, T., & Roberts, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504778112 · Cited by 88
Stem cells: a potential treatment option for kidney diseases
Liu, D., Cheng, F., Pan, S., & Liu, Z. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01751-2 · Cited by 88
New advances in stem cell research: practical implications for regenerative medicine
Ratajczak, M. Z., Jadczyk, T., Pędziwiatr, D., & Wojakowski, W. (2014) · Polish Archives of Internal Medicine · doi:10.20452/pamw.2355 · Cited by 87
Anti-Aging Strategies Based on Cellular Reprogramming
Ocampo, A., Reddy, P., & Belmonte, J. C. I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.005 · Cited by 87
Cambuli, F., Murray, A., Dean, W., Dudzińska, D., Krueger, F., Andrews, S., Senner, C. E., Cook, S. J., & Hemberger, M. (2014) · Nature Communications · doi:10.1038/ncomms6538 · Cited by 86
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2021.03.033 · Cited by 85
Lu, J. Y., Simon, M., Zhao, Y., Ablaeva, J., Corson, N., Choi, Y., Yamada, K. Y. H., Schork, N. J., Hood, W. R., Hill, G. E., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.011 · Cited by 84
Cancer: pathological nuclear reprogramming?
Goding, C. R., Pei, D., & Lü, X. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3781 · Cited by 84
Combining insoluble and soluble factors to steer stem cell fate
Dingal, P. C. D. P., & Discher, D. E. (2014) · Nature Materials · doi:10.1038/nmat3997 · Cited by 84
Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo
Doeser, M. C., Schöler, H. R., & Wu, G. (2018) · Stem Cells · doi:10.1002/stem.2842 · Cited by 83
Induced pluripotent stem (iPS) cells: A new source for cell-based therapeutics?
de Lázaro, I., Yılmazer, A., & Kostarelos, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.011 · Cited by 82
The ethics of stem cells revisited
Beriaín, Í. D. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.011 · Cited by 79
Differentiation of trophoblast cells from human embryonic stem cells: to be or not to be?
Roberts, R. M., Loh, K. M., Amita, M., Bernardo, A. S., Adachi, K., Alexenko, A. P., Schust, D. J., Schulz, L. C., Telugu, B. P. V. L., Ezashi, T., et al. (2014) · Reproduction · doi:10.1530/rep-14-0080 · Cited by 79
Roux, A. E., Zhang, C., Paw, J., Zavala-Solorio, J., Malahias, E., Vijay, T., Kolumam, G., Kenyon, C., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 78
Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer
Yamada, Y., Haga, H., & Yamada, Y. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0090 · Cited by 78
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy
Jiang, Z., Han, Y., & Cao, X. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.62 · Cited by 77
Sahu, S. K., Reddy, P., Lu, J. Y., Shao, Y., Wang, C., Tsuji, M., Núñez‐Delicado, E., Esteban, C. R., & Belmonte, J. C. I. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg1777 · Cited by 76
Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy
Zwi‐Dantsis, L., Mohamed, S., Massaro, G., & Moeendarbary, E. (2025) · Viruses · doi:10.3390/v17020239 · Cited by 76
Pesaresi, M., Sebastián-Pérez, R., & Cosma, M. P. (2018) · FEBS Journal · doi:10.1111/febs.14633 · Cited by 72
ATR expands embryonic stem cell fate potential in response to replication stress
Atashpaz, S., Shams, S. S., Gonzalez, J. M., Sebestyén, E., Arghavanifard, N., Gnocchi, A., Albers, E., Minardi, S. P., Fagà, G., Soffientini, P., et al. (2020) · eLife · doi:10.7554/elife.54756 · Cited by 72
Gonzalez, J. M., Morgani, S. M., Bone, R. A., Bonderup, K., Abelchian, S., Brakebusch, C., & Brickman, J. M. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.07.009 · Cited by 71
Specification of trophoblast from embryonic stem cells exposed to BMP4†
Roberts, R. M., Ezashi, T., Sheridan, M. A., & Yang, Y. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy070 · Cited by 70
Reprogramming: identifying the mechanisms that safeguard cell identity
Brumbaugh, J., Di Stefano, B., & Hochedlinger, K. (2019) · Development · doi:10.1242/dev.182170 · Cited by 68
Reprogramming of human cancer cells to pluripotency for models of cancer progression
Kim, J., & Zaret, K. S. (2015) · The EMBO Journal · doi:10.15252/embj.201490736 · Cited by 67
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Cipriano, A., Moqri, M., Maybury-Lewis, S. Y., Rogers-Hammond, R., de Jong, T. A., Parker, A., Rasouli, S., Schöler, H. R., Sinclair, D. A., & Sebastiano, V. (2023) · Nature Aging · doi:10.1038/s43587-023-00539-2 · Cited by 66
“Although developments in cellular reprogramming have proposed several new and promising medical avenues 19–21 , continuous expression of OSKM factors in vivo is limited by substantial safety concerns including severe weight loss, the formation of circulating totipotent stem cells and teratomas in…”
Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 66
All models are wrong, but some are useful: Establishing standards for stem cell-based embryo models
Pósfai, E., Lanner, F., Mulas, C., & Leitch, H. G. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.019 · Cited by 66
Morales‐Hernández, A., González-Rico, F. J., Román, Á., Rico-Leo, E. M., Alvarez, A. M., Sánchez, L., Macia, Á., Heras, S. R., Garcia-Perez, J. L., Merino, J. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw095 · Cited by 66
MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts
Ghasemi‐Kasman, M., Hajikaram, M., Baharvand, H., & Javan, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127878 · Cited by 66
AAV vector-mediated in vivo reprogramming into pluripotency
Senís, E., Mosteiro, L., Wilkening, S., Wiedtke, E., Nowrouzi, A., Afzal, S., Fronza, R., Landerer, H., Abad, M., Niopek, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05059-x · Cited by 64
Self-citationGalow, A.-M., & Peleg, S. (2022) · Cells · doi:10.3390/cells11030468 · Cited by 64
Metadata
- Authors
- Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., Manzanares, M., Ortega, S., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Corresponding author
- Serrano, Manuel
- Venue
- Nature
- Published
- 2013-09-11
- Volume
- 502
- Issue
- 7471
- Pages
- 340-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051454588
- Cited by
- 547
- References
- 46
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 41 · 2023: 46 · 2022: 51 · 2021: 46 · 2020: 47 · 2019: 35 · 2018: 38 · 2017: 47 · 2016: 26 · 2015: 38 · 2014: 54 · 2013: 11
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CEU Repositorio Institucional (Fundación Universitaria San Pablo CEU) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- in vivo reprogramming, induced pluripotent stem cells, teratoma, totipotency, Yamanaka factors, Oct4, SOX2, KLF4, c-Myc, Nanog, trophectoderm, embryonic stem cells, regenerative medicine
- MeSH terms
- Kruppel-Like Factor 4, Animals, Blood Cells, Cell Separation, Cells, Cultured, Ectoderm, Female, Fibroblasts, Intestines, Kidney, Male, Mice, Inbred C57BL, Organ Specificity, Pancreas, Stomach, Teratoma, Trophoblasts, Proto-Oncogene Proteins c-myc, Gene Expression Profiling, Totipotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, Embryonic Stem Cells, Cell Dedifferentiation, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells, Embryoid Bodies, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.